BENDHEIM JACK (President and CEO) sold 62.5% of their position (27.84K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $1.16M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/22/2026ACC: 0001104659-26-005914
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-27.84K
Net shares
Net seller
$1.16M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
27.84K disposed
Non-Derivative Transactions3
Class A Common Stock
Indirect
Shares
−14.69K
Price / share
$41.68
Trade value
$612.13K
% of position
33.0%
1/21/2026
44.52K→29.84K
Class A Common Stock
Indirect
Shares
−11.88K
Price / share
$41.91
Trade value
$497.66K
% of position
99.8%
1/22/2026
11.89K→17.96
Class A Common Stock
Indirect
Shares
−1.28K
Price / share
$42.68
Trade value
$54.76K
% of position
7.1%
1/22/2026
17.96K→16.68K
Total
Net shares
−27.84K
Net value
-$1.16M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 1/21/2026 | S · Sale | −14.69K | $41.68 | $612.13K | 33.0% | 44.52K | 29.84K |
| Class A Common Stock Indirect | 1/22/2026 | S · Sale | −11.88K | $41.91 | $497.66K | 99.8% | 11.89K | 17.96 |
| Class A Common Stock Indirect | 1/22/2026 | S · Sale | −1.28K | $42.68 | $54.76K | 7.1% | 17.96K | 16.68K |
| Total | −27.84K | -$1.16M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported